<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To observe the relationship of fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG), postchallenge plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (PG) (30, 60, 90, and 120 min during an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test [OGTT], as well as maximal PG during an OGTT, postchallenge <z:chebi fb="105" ids="17234">glucose</z:chebi> spikes [PGS], and <z:chebi fb="105" ids="17234">glucose</z:chebi> under the OGTT curve), and HbA1c to intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) as a marker of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: OGTT, ultrasound measurement of carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, and various <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> risk factors, such as family history of <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, and/or <z:hpo ids='HP_0010980'>hyperlipoproteinemia</z:hpo>, but without known <z:mp ids='MP_0002055'>diabetes</z:mp>, were analyzed in 582 individuals aged 40-70 years and at risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In univariate analysis, <z:hpo ids='HP_0000001'>all</z:hpo> examined glycemic parameters were significantly correlated to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The 2-h postchallenge plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> showed the strongest odds ratio (OR) of 1.88 (1.34-2.63) in relation to abnormal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> PG variables, except for 30-min <z:chebi fb="105" ids="17234">glucose</z:chebi> in OGTT, showed a significant OR, whereas the OR for HbA1c and FPG was not significant </plain></SENT>
<SENT sid="5" pm="."><plain>In logistic regression analysis, 2-h PG was identified as the strongest determinant of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> from <z:hpo ids='HP_0000001'>all</z:hpo> glycemic parameters </plain></SENT>
<SENT sid="6" pm="."><plain>The 2-h PG and PGS, but not FPG, were associated with a significant rise of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in tertiles of HbA1c </plain></SENT>
<SENT sid="7" pm="."><plain>Glycemic parameters were strongly related to each other and to many <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> risk factors </plain></SENT>
<SENT sid="8" pm="."><plain>In multivariate analysis including a variety of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> risk factors, 2-h PG was a significant independent determinant of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: PG and PGS are more strongly associated with carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> than FPG and HbA1c level and modify substantially the risk for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, estimated by HbA1c alone, in a cohort at risk for <z:mp ids='MP_0002055'>diabetes</z:mp> and in the early <z:mp ids='MP_0002055'>diabetes</z:mp> stage </plain></SENT>
</text></document>